title: A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
authors.affiliation: Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. heathe@karmanos.org
authors.forename: Elisabeth I
authors.initials: EI
authors.lastname: Heath
authors.forename: Melvin
authors.initials: M
authors.lastname: Gaskins
authors.forename: Henry C
authors.initials: HC
authors.lastname: Pitot
authors.forename: Roberto
authors.initials: R
authors.lastname: Pili
authors.forename: Winston
authors.initials: W
authors.lastname: Tan
authors.forename: Robert
authors.initials: R
authors.lastname: Marschke
authors.forename: Glenn
authors.initials: G
authors.lastname: Liu
authors.forename: David
authors.initials: D
authors.lastname: Hillman
authors.forename: Fazlul
authors.initials: F
authors.lastname: Sarkar
authors.forename: Shijie
authors.initials: S
authors.lastname: Sheng
authors.forename: Charles
authors.initials: C
authors.lastname: Erlichman
authors.forename: Percy
authors.initials: P
authors.lastname: Ivy
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy; D016227:Benzoquinones; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D047029:Lactams, Macrocyclic; D008297:Male; D015337:Multicenter Studies as Topic; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D012107:Research Design; D017828:Rifabutin / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D016227:Benzoquinones; D047029:Lactams, Macrocyclic; D017828:Rifabutin; C112765:tanespimycin; D017346:Protein Serine-Threonine Kinases; D017430:Prostate-Specific Antigen